Followers | 55 |
Posts | 2262 |
Boards Moderated | 0 |
Alias Born | 07/08/2014 |
Sunday, December 10, 2023 1:48:29 PM
Recent PCSA News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:00:25 PM
- Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results • GlobeNewswire Inc. • 10/30/2024 08:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2024 08:05:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 08:36:29 PM
- Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer • GlobeNewswire Inc. • 10/02/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:50:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:48:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:47:53 PM
- Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 12:00:21 PM
- Processa Pharmaceuticals Provides Product Pipeline and Financial Update • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri • GlobeNewswire Inc. • 08/19/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:15:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:34:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:31:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:28:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:12:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 12:00:21 PM
- Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer • GlobeNewswire Inc. • 07/30/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/22/2024 09:59:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 12:00:22 PM
- Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 06/11/2024 06:19:42 PM
- Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer • GlobeNewswire Inc. • 06/11/2024 12:20:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/29/2024 04:15:13 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM